A. Helwig

Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulin

R. Naumann, G. Ehninger, A. Neubauer, 2000, Bone Marrow Transplantation.

Pharmacokinetics of intravenous mycophenolate mofetil after allogeneic blood stem cell transplantation

G. Ehninger, U. Platzbecker, M. Bornhäuser, 2001, Clinical transplantation.

Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients.

G. Ehninger, C. Thiede, U. Platzbecker, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Treatment of relapsing leukemia after allogeneic blood stem cell transplantation by using dose-reduced conditioning followed by donor blood stem cells and GM-CSF

G. Ehninger, C. Thiede, U. Platzbecker, 2001, Annals of Hematology.

Early allogeneic blood stem cell transplantation after modified conditioning therapy during marrow aplasia: stable remission in high-risk acute myeloid leukemia

G. Ehninger, M. Schaich, C. Thiede, 2001, Bone Marrow Transplantation.

Double lumen port access in patients receiving allogeneic blood stem cell transplantation

G. Ehninger, M. Schaich, T. Illmer, 2001, Bone Marrow Transplantation.

Successful transplantation of CD34+ selected peripheral blood stem cells from an unrelated donor in an adult patient with Diamond–Blackfan anemia and secondary hemochromatosis

G. Ehninger, M. Bornhäuser, A. Berndt, 2005, Bone Marrow Transplantation.

Diabetes insipidus in a patient with a highly malignant B-cell lymphoma and stomatitis.

G. Ehninger, M. Breidert, T. Kittner, 2012, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Graft Versus Host Disease Prophylaxis with Everolimus and Tacrolimus in Patients with Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukaemia (AML) Receiving Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT).

A. Kiani, G. Ehninger, U. Platzbecker, 2006 .

Successful combination of anti‐cd33 antibody (gemtuzumab ozogamicin) and minimal conditioning before second allografting in recurrent acute myeloid leukaemia

G. Ehninger, C. Thiede, M. Bornhäuser, 2003, British journal of haematology.

SUCCESSFUL PREEMPTIVE CIDOFOVIR TREATMENT FOR CMV ANTIGENEMIA AFTER DOSE-REDUCED CONDITIONING AND ALLOGENEIC BLOOD STEM CELL TRANSPLANTATION

G. Ehninger, A. Rethwilm, C. Thiede, 2001, Transplantation.